Dr Michael Baker presents at AusBiotech Invest 2025
Arovella is pleased to announce that its CEO and MD, Dr Michael Baker, will today present at Australia’s premier life science investment conference, AusBiotech Invest.
Dr Baker will present Arovella’s iNKT cell therapy platform and described how Arovella’s technology provides important advantages over existing T-cell therapies and has the potential to be applied to both blood cancers and solid tumours.
